While nanobodies present numerous benefits, there are challenges associated with their use. One of the primary challenges is the potential for immunogenicity, as foreign proteins can elicit an immune response in humans. However, advancements in genetic engineering techniques are being employed to humanize nanobodies, reducing their immunogenicity. Furthermore, the production and purification processes need to be optimized to ensure consistent quality and yield.
